Dose dependent increase in human coronary blood flow velocity following an IV bolus of CVT-3146, a novel A2a adenosine receptor agonist: A potential agent for the use in pharmacological stress testing for myocardial perfusion imaging

被引:0
|
作者
Kerensky, RA
von Mering, GO
Kent, KM
Cannon, RO
Belardinelli, L
机构
[1] Univ Florida, Gainesville, FL USA
[2] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[3] CV Therapeut, Palo Alto, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3054
引用
收藏
页码:618 / 618
页数:1
相关论文
共 10 条
  • [1] Myocardial perfusion Imaging with a novel selective a2a adenosine receptor agonist (CVT-3146): Important differences in radiotracer behavior
    Jadbabaie, F
    Meoli, DF
    Bourke, BN
    Purushothaman, K
    Brown, L
    Belardinelli, L
    Sinusas, AJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 443A - 444A
  • [2] Pharmacologic stress SPECT myocardial perfusion Imaging with a selective A2A agonist: results of a pilot study comparing adenosine with CVT-3146
    Hendel, RC
    Mahmarian, JJ
    Cerqueira, MD
    Bateman, TM
    Leppo, JA
    Iskandrian, AE
    [J]. CIRCULATION, 2003, 108 (17) : 636 - 636
  • [3] Initial results regarding the safety, tolerability, and hemodynamic effects of CVT-3146, a selective adenosine A2A agonist, in patients undergoing pharmacologic stress SPECT myocardial perfusion imaging
    Hendel, RC
    Mahmarian, JJ
    Bateman, TM
    Cerqueira, MD
    Iskandrian, AE
    Jerling, M
    Abdallah, HY
    Leppo, JA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 367A - 367A
  • [4] A randomized, placebo-controlled, crossover, ascending dose tolerance and pharmacokinetic study of CVT-3146: A novel agent for potential use in myocardial perfusion imaging.
    Cannon, RO
    Freestone, S
    Mair, SJ
    Jerling, M
    Skettino, SL
    Bellardinelli, L
    Wolff, AA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P31 - P31
  • [5] Effects of apadenoson, a selective adenosine A2a receptor agonist for myocardial perfusion imaging, on coronary blood flow velocity in conscious patients
    Kern, Morton J.
    Hodgson, John M.
    Dib, Nabil
    Mittleman, Robert S.
    Crane, Paul D.
    [J]. CIRCULATION, 2006, 114 (18) : 582 - 582
  • [6] Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs:: Potential for use in myocardial perfusion imaging
    Trochu, JN
    Zhao, G
    Post, H
    Xu, XB
    Belardinelli, L
    Belloni, FL
    Hintze, TH
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (01) : 132 - 139
  • [7] Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans
    Hsiao D. Lieu
    John C. Shryock
    Gregory O. von Mering
    Toufigh Gordi
    Brent Blackburn
    Ann W. Olmsted
    Luiz Belardinelli
    Richard A. Kerensky
    [J]. Journal of Nuclear Cardiology, 2007, 14 : 514 - 520
  • [8] Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans
    Lieu, Hsiao D.
    Shryock, John C.
    von Mering, Gregory O.
    Gordi, Toufigh
    Blackburn, Brent
    Olmsted, Ann W.
    Belardinelli, Luiz
    Kerensky, Richard A.
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2007, 14 (04) : 514 - 520
  • [9] Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging
    Udelson, JE
    Heller, GV
    Wackers, FJT
    Chai, A
    Hinchman, D
    Coleman, PS
    Dilsizian, V
    DiCarli, M
    Hachamovitch, R
    Johnson, JR
    Barrett, RJ
    Gibbons, RJ
    [J]. CIRCULATION, 2004, 109 (04) : 457 - 464
  • [10] Hyperemic coronary blood flow induced by selective adenosine A2A receptor stimulation: First report in patients of a well tolerated novel agent for stress imaging
    Kern, MJ
    Hodgson, JM
    Rossen, JD
    Fischell, TA
    Barrett, RJ
    Bitar, SR
    Eisenhauer, MD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 299A - 299A